...
首页> 外文期刊>Biomarkers >ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects
【24h】

ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects

机译:ADAM10基因在阿尔茨海默氏病患者和轻度认知障碍患者血细胞中的表达

获取原文
获取原文并翻译 | 示例
           

摘要

ADAM10 is a potential biomarker for Alzheimer's disease (AD). ADAM10 protein levels are reduced in platelets of AD patients. The aim was to verify the total blood and platelet ADAM10 gene expression in AD patients and to compare with mild cognitive impairment (MCI) and healthy subjects. No significant differences in ADAM10 gene expression were observed. Therefore, the decrease of ADAM10 protein in platelets of AD patients is not caused by a reduction in ADAM10 mRNA. Further studies must be performed to investigate other pathways in the down regulation of ADAM10 protein.
机译:ADAM10是阿尔茨海默氏病(AD)的潜在生物标志物。 AD患者血小板中ADAM10蛋白水平降低。目的是验证AD患者的总血液和血小板ADAM10基因表达,并与轻度认知障碍(MCI)和健康受试者进行比较。没有观察到ADAM10基因表达的显着差异。因此,AD患者血小板中ADAM10蛋白的降低不是由ADAM10 mRNA的降低引起的。必须进行进一步的研究以研究ADAM10蛋白下调的其他途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号